Hua Hong Semiconductor's (688347.SH) additional issuance for acquisition has been approved by the Shanghai State-owned Assets Supervision and Administration Commission.

06:18 11/02/2026

Huahong Company (688347.SH) announced that the company plans to purchase 97.4988% equity of Shanghai Huahong (Group) Co., Ltd., Shanghai Integrated Circuit Industry Investment Fund Co., Ltd., National Integrated Circuit Industry Investment Fund Phase II Co., Ltd., and Shanghai Guotou Leading Integrated Circuit Private Equity Investment Fund Partnership Enterprise (Limited Partnership) through the issuance of shares held by these entities, and raise supporting funds.

Hua Hong Semiconductor (688347.SH) announced that the company plans to purchase 97.4988% equity of Shanghai Huahong Microelectronics Co., Ltd. held by Shanghai Huahong (Group) Co., Ltd., Shanghai Integrated Circuit Industry Investment Fund Co., Ltd., National Integrated Circuit Industry Investment Fund Phase II Co., Ltd., and Shanghai Guotou Xian Dao Integrated Circuit Private Equity Investment Fund Partnership Enterprise (Limited Partnership) through issuing shares, and to raise supporting funds. Recently, the company received the approval from the Shanghai State-owned Assets Supervision and Administration Commission, which was forwarded by its indirectly controlling shareholder Shanghai Huahong (Group) Co., Ltd., regarding the asset restructuring of Hua Hong Semi Limited. The Shanghai State-owned Assets Supervision and Administration Commission has conditionally approved the company's proposed transaction plan.

ABBISKO-B(02256): The FGFR4 inhibitor erdafitinib has completed the global phase I study extension stage with the first patient dosed in the United States.

VOBILE GROUP (03738) has reached a strategic cooperation with Star Road Technology to jointly promote the overseas tokenization of cultural and creative intellectual property (IP).

$1 billion buyback can't hide the decline: Lyft (LYFT.US) Q4 revenue falls short of expectations, Q1 guidance is weak, and the market votes with their feet on the self-driving vision.

ABBISKO-B(02256): The FGFR4 inhibitor erdafitinib has completed the global phase I study extension stage with the first patient dosed in the United States.

VOBILE GROUP (03738) has reached a strategic cooperation with Star Road Technology to jointly promote the overseas tokenization of cultural and creative intellectual property (IP).

$1 billion buyback can't hide the decline: Lyft (LYFT.US) Q4 revenue falls short of expectations, Q1 guidance is weak, and the market votes with their feet on the self-driving vision.